Positive peritoneal cytology (PPC) is associated with advanced disease and is highly specific in predicting unresectability of pancreatic adenocarcinoma, resulting in decreased survival. Antecedent fine-needle aspiration is not associated with an increased incidence of PPC, nor does it have a significant impact on overall survival.
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Patients with pancreatic cancer who are to be treated with curative or palliative procedures appear to benefit from referral to a high-volume provider.
